Welcome To Website IAS

Hot news
Achievement

Independence Award

- First Rank - Second Rank - Third Rank

Labour Award

- First Rank - Second Rank -Third Rank

National Award

 - Study on food stuff for animal(2005)

 - Study on rice breeding for export and domestic consumption(2005)

VIFOTEC Award

- Hybrid Maize by Single Cross V2002 (2003)

- Tomato Grafting to Manage Ralstonia Disease(2005)

- Cassava variety KM140(2010)

Centres
Website links
Vietnamese calendar
Library
Visitors summary
 Curently online :  59
 Total visitors :  7651750

Report Highlights the Cost of Europe Saying `No` to Gene Editing

Breakthrough Institute and the Alliance for Science released a report about the economic costs of regulating new genomic techniques in the European Union. The report, titled The €3 Trillion Cost of Saying No: How the EU Risks Falling Behind in the Bioeconomy Revolution, presents that the EU's policies are not up-to-date, classifying gene-edited crops as genetically modified organisms, which is governed by a 2001 regulatory framework.

Breakthrough Institute and the Alliance for Science released a report about the economic costs of regulating new genomic techniques in the European Union. The report, titled The €3 Trillion Cost of Saying No: How the EU Risks Falling Behind in the Bioeconomy Revolution, presents that the EU's policies are not up-to-date, classifying gene-edited crops as genetically modified organisms, which is governed by a 2001 regulatory framework. Thus, the NGT regulations hamper economic advancement, employment, and environmental sustainability in the continent and other regions.

 

The highlights of the report include the following:

  • - NGTs have the potential to contribute to economic growth through the agriculture and food; materials, chemicals and energy; and human health sectors.
  • - The potential economic benefits of NGT use per year from 2020 up to 2040 reach 2020 billions of euros in order to calculate the opportunity cost of non-adoption. 
  • - Non-adoption of NGTs led to economic benefits foregone to the EU, amounting to €171-335 billion per year. This compounds to an economic loss, estimated at over €3 trillion of economic benefits over a decade. 

 

Download the report for more information.

https://www.isaaa.org/kc/cropbiotechupdate/ged/article/default.asp?ID=20513

 

Trở lại      In      Số lần xem: 178

[ Tin tức liên quan ]___________________________________________________

 

Designed & Powered by WEBSO CO.,LTD